REGN

Regeneron Pharmaceuticals Inc (NASDAQ: REGN) FY 2026 Corporate Conference

Regeneron Pharmaceuticals Inc (NASDAQ: REGN) FY 2026 Other Release

Regeneron Pharmaceuticals Inc (NASDAQ: REGN) Q4 2025 Earnings Call dated Jan. 30, 2026 Corporate Participants: Ryan Crowe — Senior Vice…

Regeneron Pharmaceuticals Inc (NASDAQ: REGN) Q2 2025 Earnings Call dated Aug. 01, 2025 Corporate Participants: Ryan Crowe — Senior Vice…

Regeneron Pharmaceuticals Inc (NASDAQ: REGN) Q3 2025 Earnings Call dated Oct. 28, 2025 Corporate Participants: Ryan Crowe — Regeneron Pharmaceuticals,…

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on Thursday reported a decline in adjusted earnings for the first quarter of 2023, despite…

Regeneron Pharmaceuticals Inc  (NASDAQ: REGN) Q1 2023 Earnings Call dated May. 04, 2023 Corporate Participants: Ryan Crowe — Vice President, Investor Relations…

Regeneron Pharmaceuticals Inc (NASDAQ: REGN) Q4 2022 earnings call dated Feb. 03, 2023 Corporate Participants: Ryan Crowe — Vice President, Investor Relations…

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on Friday reported a sharp fall in fourth-quarter revenues and adjusted earnings. Total revenues plunged…

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) Q3 2022 Earnings Call dated Nov. 03, 2022. Corporate Participants: Ryan Crowe — Vice President, Investor Relations Leonard…